Melior Discovery Inc (Exton, PA, USA) has pioneered a unique “high throughput” in vivo pharmacology platform (theraTRACE?) able to systematically identify novel indications for pre-clinical and development stage drugs. theraTRACE? is widely used by both multinational pharmaceutical and start-up biopharmaceutical companies alike to fully explore the therapeutic potential of their drug candidates.
Melior has also leveraged this expertise to build a high quality, onshore, preclinical services capability offering in vivo efficacy models in a broad range of therapeutic areas, pharmacokinetic evaluations, specialized animal models and bioanalytical services to drug developers worldwide.
-
所属行业
-
制药业
-
规模
-
11-50 人
-
总部
-
Exton,PA
-
类型
-
私人持股
-
创立
-
2005
-
领域
-
In vivo pharmacology、in vivo models of efficacy、phenotypic screening、drug repurposing、drug repositioning、drug reprofiling、multiplexing、behavioral assays、rodent models of disease、diabetes、Parkinson's Disease和theraTRACE